Colchicine could serve as treatment for outpatients of COVID-19: MHI

▴ Colchicine could serve as treatment for outpatients of COVID-19: MHI
COLCORONA is a non-contact, home, randomized, double-blind, placebo-controlled study conducted in Canada, the United States, Europe, South America, and South Africa

The Montreal Heart Institute (MHI) announced today that the COLCORONA clinical trial will continue to recruit non-hospitalized adult patients with COVID-19 as recommended by the control committee of independent data (DMC), following a second internal analysis.

"With the sharp increase in COVID-19 cases around the world, it is increasingly important that we continue to investigate treatments that not only help hospitalized patients with severe illness, but also those with milder symptoms and are in their homes ", highlighted Dr Jean-Claude Tardif , director of the Research Center at MHI, professor of Medicine at the University of Montreal , and COLCORONA chief researcher. "We want to complete patient enrollment in this large study in the next month and we hope that colchicine will reduce the risk of complications from COVID-19."

COLCORONA is a non-contact, home, randomized, double-blind, placebo-controlled study conducted in Canada, the United States, Europe, South America, and South Africa. It seeks to determine whether colchicine can reduce the risk of serious complications linked to COVID-19. This is one of the few current large-scale COVID-19 studies in which out-of-hospital patients can participate. 

COLCORONA is coordinated by the Montreal Health Innovations Coordination Center (MHICC) and is funded by the Government of Quebec , the Bill & Melinda Gates Foundation and the National Heart, Lung, and Blood Institute (NHLBI) of the United States National Institutes of Health (NIH). CGI, Dacima and Pharmascience are also COLCORONA collaborators.

The Montreal Cardiology Institute and its partners around the world would like to thank all the researchers and the thousands of participants for their continued participation in the COLCORONA study.

Tags : #MontrealHeartInstitute #LatestPharmaNews30thNov #LatestResearchonCOVIDTreatment30thNov #Canada #UnitedStates #BillMelindaGatesFoundation

About the Author


Team Medicircle

Related Stories

Loading Please wait...

-Advertisements-




Trending Now

Sexual wellness superstore, Love Depot launches digital campaign to deliver every desireMarch 28, 2024
Recharge Your Life: Simple Ways to Boost Your Physical and Mental EnergyMarch 28, 2024
The Neurological Toll of Common Household Chemicals: Insights from Recent ResearchMarch 28, 2024
The Aging Puzzle: Decoding the Mechanisms of AgingMarch 28, 2024
The Double-Edged Sword of Kala-azar Treatment: Shedding Light on Eye ComplicationsMarch 28, 2024
FTCCI Launches Industry-Academia Connect to improve the employability of Engineering Graduates and address the growing demand for Talent in Emerging TechMarch 27, 2024
NTT and Olympus Begin World's First Joint Demonstration Experiment of Cloud Endoscopy SystemMarch 27, 2024
NTT and Olympus Begin World's First Joint Demonstration Experiment of Cloud Endoscopy SystemMarch 27, 2024
2nd Edition of IIFL JITO Ahimsa Run for peace & for non-violence to be held on 31st MarchMarch 27, 2024
Brij Hotels Announced 4 Million in Series A Funding March 27, 2024
Combatting Childhood Sedentariness: The Key to Preventing Premature Vascular DamageMarch 27, 2024
Crucial Findings: Unlocking Paths to Combat Ebola's DevastationMarch 27, 2024
Guarding Against Disease: The Crucial Role of Oral Hygiene in Preventive HealthcareMarch 27, 2024
Sanofi & Cipla announce exclusive distribution partnership to expand reach of CNS portfolio in IndiaMarch 26, 2024
Surmandal's Tribute to the Legends of Hindustani Classical MusicMarch 26, 2024
In Moscow, over 350,000 mammograms have been analyzed using artificial intelligence as part of the compulsory health insurance programMarch 26, 2024
Embark on a Creative Journey: "Kala For A Cause" Unveils Pottery Workshop Series March 26, 2024
Healthtech pioneer Aurora Innovation appoints new CEO – expands in Europe with service that streamlines patient-healthcare interactionMarch 26, 2024
In A Rare Feat, 45 YO Woman Walks Within 6 Hrs. Of Dual Robotic Surgery In A Single Operation At HCGMCCMarch 26, 2024
Improve Cancer Care through Automated CT Analysis: Oncoshield – CTMarch 26, 2024